氢分子对骨质疏松作用临床初探研究分析

吴 波以, 谢 楚海
广州医科大学附属第二医院骨科

摘要


目的：观察氢分子对骨质疏松的临床作用。方法：选择经双能量骨密度仪首次检查确诊并且没有经历抗骨质疏松治疗的6位骨量减少或骨质疏松症志愿者，采用600ml/分钟氢吸入器居家吸入氢气，每天吸入氢气2小时，同时服用碳酸钙1000mg、维生素D31000IU,持续观察期3～6个月，需要时可以延长观察期，定期复查骨代谢标志物和骨密度，观察氢分子对骨质疏松的临床作用。结果：吸入氢气1个月后，4例显示骨吸收标志物β-CrossLaps下降，吸入氢气2个月后，5例较吸入氢气前基础值下降超过35%，3例骨密度有改善，其中1例比较严重的骨质疏松症志愿者吸入氢气半年骨密度恢复了1/3，另1例骨量减少志愿者吸入氢气1年骨密度恢复正常。结论：氢分子通过抑制破骨细胞对人体骨质疏松具有改善、逆转作用。居家吸入氢气方便、安全，作为骨质疏松症慢性病的防治措施，未来希望可期。

关键词


氢分子医学；骨质疏松症；骨代谢标志物；骨密度

全文:

PDF


参考


[1]中国疾病预防控制中心，中华医学会骨质疏松和骨矿盐疾病分会．中国骨质疏松症流行病学调查报告(2018)[M]．北京:人民卫生出版社，2021．

[2]Wang L,Yu W,Yin X,et al.Prevalence of osteoporosis and fracture in China:The China Osteoporosis Prevalence Study [J].JAMA Netw Open,2021,4:e2121106．

[3]付晓宁,胡朝晖.骨代谢生化指标对于骨质疏松症诊断与治疗的临床意义[J].中国骨与关节损伤杂志,20 18,33(9):1003-1005.

[4]林远方,卿茂盛,李昂,等.雌激素抗氧化作用与绝经后骨质疏松症的关系[J].中国骨质疏松杂志，20 06,12(6):565-567.

[5]Li H,Huang C,Zhu J,et al.Lutein Suppresses Oxidative Stress and Inflammation by Nrf2 Activation in an Osteoporosis Rat Model [J].Medical Science Monitor,2018 (24):5071-5075.

[6]SinghT,NewmanAB.Inflammatory markers in population studies of aging[J].Ageing Res Rev,2011,10(3): 319—329

[7]Vinita Sharma,Mohammad Murtaza Mehdi. Oxidative stress, inflammation and hormesis: The role of dietary and lifestyle modifications on aging [J].Neuro chem Int.2023 Mar ; 164:105490.

[8]Jingmin Che,Jiancheng Yang ,Bin Zhao,et al.HO-1: A new potential therapeutic target to combat osteoporosis[J]. Eur J Pharmacol 2021 Sep 5; 906:174-219.

[9]原发性骨质疏松症诊疗指南 (2022)[J].中华骨质疏松和骨矿盐疾病杂志，2022,15(6): 573-611.

[10]夏世金, 孙涛, 吴俊珍. 自由基、炎症与衰老[J]. 实用老年医学, 2014, 028(002):100-103.

[11]Chavan S N,More U,Mulgund S,et al.Effect of supplementation of vitamin C and E on oxidative stress in osteoporosis[J].Indian Journal of Clinical Biochemistry,2007, 22(2):101-105.

[12]Ikuroh Ohsawa,Masahiro Ishikawa,Kumiko Takahashi,et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J].Nat Med. 2007 Jun;13(6):688-94.

[13]Gang Wu,Lei Pan,Jing Sun, et al.Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation [J].Menopause.2019,26(7): 785-792.

[14]Jialiang Guo,Weichong Dong,Lin Jin,et al. Hydrogen-rich saline prevents bone loss in diabetic rats induced by streptozotocin[J]. Int Orthop.2017,41(10):2119 -2128.

[15]许爱萍.骨代谢标志物与绝经后妇女骨质疏松症的相关性研究[J].检验医学与临床,2009,(24):2109-211 0.

[16]黎卓华,崔敏涛，吴丽川,等.3种骨标志物在绝经后妇女骨质疏松诊断中的研究[J]. 国际检验医学杂志，2014,15(7): 914-915.

[17]Krege JH,Lane NE,Harris JM,et al.PINP as a biological response marker during teriparatide treatment for osteoporosis.Osteoporos Int[J].2014; 25(9):2159-2171.

[18]徐苓. 骨质疏松症[M].上海科学技术出版社，2011. P:243.

[19]Lauren A Burt,Emma O Billington,Marianne S Rose,et al. Adverse Effects of High-Dose Vitamin D Supplementation on Volumetric Bone Density Are Greater in Females than Males [J]. J Bone Miner Res. 2020 Dec;35(12): 2404-2414.

[20]Jacques P Brown,Richard L Prince, Chad Deal,et al. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass:A Randomized, Blinded, Phase 3 Trial[J]. J Bone Miner Res. 2009,24:153–161.


Refbacks

  • 当前没有refback。